<DOC>
	<DOCNO>NCT01667926</DOCNO>
	<brief_summary>Ketamine infusion result acute reduction global depression score severity suicidal ideation . The investigator therefore plan investigate feasibility efficacy repeat intravenous administration ketamine severely depressed , treatment resistant patient . The result study could lead development new strategy treat depression .</brief_summary>
	<brief_title>Ketamine Versus Placebo Treatment Resistant Major Depressive Disorder</brief_title>
	<detailed_description />
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<criteria>Outpatient sever treatment resistant depression Currently depress Currently regular psychiatric care On aggressive antidepressant regimen , stable 4 week . No history major psychiatric illness , include bipolar No history psychosis No history drug abuse No major medical illness unstable medical problem</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>